Series B funding round for Atalanta Therapeutics raising $97M in January 2025
Series B funding round for Atalanta Therapeutics raising $97M in January 2025
| Investor | Firm Type | Partner |
|---|
EQT PartnersLEAD | Venture Capital | — |
Sanofi VenturesLEAD | Corporate Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$207M
Top Valuation
-
Atalanta Therapeutics raised $97M in a Series B round.
The round was announced on 01/01/25.
The round was led by Sanofi Ventures, LSP.